King Charles Shares a Rare Update on His Cancer Battle With a Fan After More Than a Year of Treatments
When you buy through links on our articles, Future and its syndication partners may earn a commission.
King Charles shocked royal fans when he announced his cancer diagnosis in February 2024 following a procedure for an enlarged prostate. Although the palace has never specified what type of cancer he has—other than clarifying that it's not prostate cancer—The King has made a few brief comments about his health battle while keeping up a busy schedule of royal engagements. Fifteen months into treatment, the monarch has given a rare—and encouraging—update on his health.
The King spoke with a former cancer patient while visiting the city of Bradford with Queen Camilla on Thursday, May 15, and florist Safeena Khan shared the details of their conversation (via the Mirror). Khan—who gave King Charles a bouquet of flowers inspired by his garden at Highgrove House—met the monarch along with other local business owners at Impact Hub Yorkshire.
"He asked me how I was, and I asked him how he was. There was some pleasantries towards the end, but it was a lovely conversation," she said. When she inquired about his health these days, King Charles "gave her the 'thumbs up'" and said, "I'd like to think I'm on the better side."
The King has been receiving outpatient treatment at the London Clinic since he was diagnosed early last year, and despite a minor "bump in the road" when he was briefly hospitalized for observation in late March, his cancer treatments seem to be progressing as hoped. Per the Mirror, palace insiders stated The King was "very much headed in the right direction" after his hospitalization earlier this spring.
During his visit to Bradford, King Charles received a special jacket from local tailor Imran Khan—and gave out more than one unexpected hug. In an Instagram Reel from GB News royal correspondent Cameron Walker, Khan has The King help stitch a label on the intricately embroidered piece before saying, "Can I have a hug?"
Fifteen-year-old Florence McGrellis also gave the monarch a surprise cuddle at the Hockney Gallery, declaring, "I'm a hugger" and calling her experience with royalty "awesome," per the media outlet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
20 minutes ago
- Medscape
NICE Recommends Earlier Treatments for Chronic Heart Failure
Thousands of patients in England with early-stage chronic heart failure could benefit from earlier access to effective drug therapies under new draft guidance from the National Institute for Health and Care Excellence (NICE). The guidance, which updates NICE's 2018 clinical recommendations, advises earlier treatment for heart failure with reduced ejection fraction ( HFrEF). NICE said that clinical practice is changing and that medicines should be offered up to a year earlier in the treatment pathway. The changes could prevent 3000 deaths and 5500 hospital admissions annually in England, the regulator estimated. Earlier Use of Combination Therapies The four pillars of treatment for HFrEF include: Angiotensin-converting enzyme inhibitors (ACEIs) Beta-blockers (BBs) Mineralocorticoid receptor antagonists (MRAs) Sodium-glucose cotransporter-2 (SGLT2) inhibitors NICE said these drugs should be prescribed earlier, without the need to optimise the dose of any one medicine before introducing another. SGLT2 inhibitors such as empagliflozin and dapagliflozin should now be offered at the start of the treatment pathway, rather than after other medications have been fully titrated – a process that could take over a year. NICE also advised that angiotensin receptor neprilysin inhibitors (ARNIs) should be offered if a person cannot tolerate an ACEI, rather than only to patients stabilised on ACEIs or angiotensin receptor blockers (ARBs). Both SGLT2 inhibitors and ARNIs could now be initiated by GPs with advice from heart failure specialists, potentially speeding up patient access. Responding to Evolving Evidence 'We've been able to review the emerging evidence quickly to keep pace with changes in the treatment landscape and make recommendations that will widen access to effective treatments,' said Eric Power, deputy director in NICE's centre for guidelines. He added that the new approach could help reduce emergency hospital admissions and improve quality of life for people living with heart failure. Updated Diagnostic and Monitoring Advice NICE also updated guidance on diagnosis and monitoring, particularly for iron deficiency and anaemia in patients with HFrEF. Clinicians should: Assess iron status and check for anaemia using transferrin saturation (TSAT), serum ferritin, and haemoglobin Consider intravenous iron for patients with haemoglobin under 150 g/L and TSAT under 20% or ferritin under 100 ng/mL If iron deficiency anaemia is found, alternative causes beyond heart failure should be investigated. Revised Biomarker Recommendations In addition, NICE advised clinicians to be aware that: An NT-proBNP level of less than 400 nanogram per litre (47 pmol per litre) in an untreated person makes a diagnosis of heart failure less likely. The level of serum natriuretic peptide does not differentiate between heart failure with preserved, mildly reduced, and reduced ejection fraction. Obesity, African or African-Caribbean ethnic background, or treatment with a diuretic, an ACEI, an ARNI, an ARB, a beta-blocker, or a MRA could reduce serum natriuretic peptide levels. High levels of natriuretic peptides may also be caused by non-cardiac conditions such as COPD, diabetes, sepsis, and liver or kidney disease. Heart Failure Prevalence Almost one million people in the UK are currently living with heart failure, with 200,000 new diagnoses each year. The average age at diagnosis is 76. Rising life expectancy and obesity are driving the increased incidence and prevalence of the disease.
Medscape
3 hours ago
- Medscape
Napping Patterns Tied to All-Cause Mortality Risk
SEATTLE — Timing, duration, and variability of daytime napping are associated with an increased risk for mortality in middle- to older-aged adults, new research showed. An analysis of UK Biobank data, which included more than 86,000 non-shift workers, showed that longer naps, greater variability in daytime napping duration, and higher percentages of naps around noon and in the early afternoon are associated with an increased risk for all-cause mortality. 'Our study fills a gap in knowledge by showing that it's not just whether someone naps but how long, how variable, and when they nap may be meaningful indicators of future health risk,' lead investigator Chenlu Gao, PhD, with the Division of Sleep Medicine, Harvard Medical School and Massachusetts General Hospital in Boston, told Medscape Medical News . 'However, it's important to emphasize that these are associations. Because the design of this study is observational, we cannot determine whether napping patterns cause higher mortality risk or simply reflect underlying health conditions,' Gao cautioned. The findings will be presented on June 11 at SLEEP 2025. An Early Indicator of Declining Health? 'While many studies have examined the links between sleep and mortality, they have largely focused on nighttime sleep, often overlooking daytime sleep. However, napping is an important component of the 24-hour sleep-wake cycle and may carry its own health implications,' Gao explained. For the study, the researchers examined whether actigraphy-measured objective daytime napping behaviors predict all-cause mortality in 86,565 non-shift workers. The cohort had a mean age of 63 years at baseline, and 57% were women. They were monitored by actigraphy for 7 days, and daytime napping was defined as sleep between 9 AM and 7 PM. Median nap duration was 0.40 h/d, with 34% of naps taken between 9 and 11 AM, 10% between 11 AM and 1 PM, 14% between 1 and 3 PM, 19% between 3 and 5 PM, and 22% between 5 and 7 PM. During a follow-up period of up to 11 years, 5189 (6.0%) participants died. Overall, as individuals aged, naps tended to become longer and more irregular, with timing shifting toward the afternoon. After adjusting for potential confounders, including demographics, BMI, smoking, alcohol use, and nighttime sleep duration, longer nap duration was associated with an increased risk for mortality (hazard ratio [HR], 1.20 for 1 SD; P < .0001). Greater intraindividual variability (HR, 1.14 for 1 SD; P < .0001) and a higher percentage of naps between 11 AM and 1 PM (HR, 1.07 for 1 SD; P = .0005) and between 1 and 3 PM (HR, 1.07 for 1 SD; P = .0002) were also associated with an increased risk for mortality. 'These findings highlight the potential importance of considering napping behaviors in risk stratification of mortality in middle- to older-aged adults,' the researchers noted in their abstract. 'Longer or more irregular naps may reflect poor nighttime sleep, circadian rhythm disruption, or underlying health conditions such as cardiovascular disease, metabolic disorders, depression, or early neurodegenerative changes. Our findings suggest that certain patterns of napping could serve as early indicators of declining health,' said Gao. However, the researchers did not specifically test these mechanisms in this study, and further research is needed to clarify the biological pathways underlying these associations, Gao cautioned. Ask About Napping Commenting on the research for Medscape Medical News , James A. Rowley, MD, professor of medicine and program director, Sleep Medicine Fellowship, Rush University Medical Center in Chicago, said the 'major take-home message is that if physicians ask about a patient's sleep habits, they should also be asking about napping, not just the nocturnal sleep period. In other words, physicians should be asking their patients, 'do you nap during the day?'' 'One cannot ignore daytime napping and an evaluation for the etiology of daytime napping is important,' said Rowley. Rowley noted that the key questions to consider include whether the patient is obtaining sufficient nocturnal sleep. Could an underlying sleep disorder — such as sleep apnea or restless legs syndrome — be contributing? Might another medical condition, such as chronic heart failure or chronic obstructive pulmonary disease, be disrupting nighttime sleep and prompting daytime napping?
Yahoo
4 hours ago
- Yahoo
Residents at care home enjoy visit from 'therapeutic' alpacas
Residents at a Peterborough care home were surprised by a visit from some alpacas. The group of animals from Gorefield Alpacas spent the day at Longueville Court care home on May 28. The residents and their families spent the afternoon feeding the alpacas and learning about them. Longueville Court care home residents enjoy alpaca visit (Image: Longueville Court care home) General manager Krzysztof Krzysztofiak said: "Our residents have really enjoyed their unusual visitors today. "We knew that having Gorefield Alpacas here would be a bit of fun for all our residents, especially as some find it difficult to go on many outings in our minibus. "We are always looking for new activities for the residents and today we have seen the enjoyment and the therapeutic influence animals can have on people." Longueville Court care home residents enjoy alpaca visit (Image: Longueville Court care home) Teal Cunningham, a resident at the care home, said: "As a child I used to love all the animals on the nearby farm. "Today was very enjoyable, and it was wonderful that the animals were here and we got to feed them." Longueville Court care home provides residential care, nursing care and dementia care for 104 residents. Keep up to date with the latest news across Peterborough by signing up to our newsletter email alerts here Have you got a story you want to share with us? Get in touch at: news@
